The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.
Armata HL, Garlick DS, Sluss HK. The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. Cancer Res. 2007 Dec 15; 67(24):11696-703.